Wednesday, 29 August 2012

Catalyst Pharmaceutical Partners-Definitive Agreements-Common Stock

Catalyst Pharmaceutical Partners, Inc. Raises $6 Million in Registered Direct Offering

CORAL GABLES, Fla., Aug. 28, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has entered into definitive agreements to sell (i) 4.0 million shares of the Company's common stock, and (ii) common stock purchase warrants to purchase an aggregate of 1.2 million shares of the Company's common stock, in a registered direct public offering. The aggregate offering price for each share and corresponding warrant is $1.50, resulting in gross proceeds of $6 million. The common stock purchase warrants have a five year-term and an exercise price of $2.08 per share. (Source: Medical News (via PRIMEZONE)) read more..

No comments:

Post a comment